ARCHIVES

FDA News: Zydelig approved in three B-cell blood cancers

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Weak Electromagnetic Fields Can Possibly Stabilize Tumors

September 30, 2011

Roswell Park Wins High Priority Score, Full Budget Recommendation For Core Grant.

January 11, 2008

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

More Changes In Carcinogenesis Program At NCI: Gori, Workshops Out, Branch Chiefs Running It

November 18, 1977

St. Jude Begins $100 Million Expansion Program

December 4, 1987

NCI Support Crucial for Israel cancer Studies; Weizmann Top Recipient

June 17, 1977